• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球胆管癌的发病率和死亡率

Worldwide Incidence and Mortality of Biliary Tract Cancer.

作者信息

Baria Katherine, De Toni Enrico N, Yu Binbing, Jiang Zhuoxin, Kabadi Shaum M, Malvezzi Matteo

机构信息

Global Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, Maryland.

Department of Internal Medicine II, Ludwig Maximilian University of Munich, München, Germany.

出版信息

Gastro Hep Adv. 2022 Apr 15;1(4):618-626. doi: 10.1016/j.gastha.2022.04.007. eCollection 2022.

DOI:10.1016/j.gastha.2022.04.007
PMID:39132071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11307584/
Abstract

BACKGROUND AND AIMS

Biliary tract cancer (BTC) consists of a group of hepatic and perihepatic tumors that are in close proximity but are anatomically different, including gallbladder cancer (GBC), cholangiocarcinoma (extrahepatic and intrahepatic [ICC]), and ampulla of Vater cancer (AVC). Most epidemiologic research has focused on 1 or more anatomic subtypes, or does not differentiate BTC from hepatocellular carcinoma or other primary liver cancers. Here, we provide a descriptive update on global incidence and mortality rates for BTC, overall and by anatomic subtypes.

METHODS

Age-standardized rates (per 100,000 person-years) were derived from the International Agency for Research on Cancer, Cancer Incidence in Five Continents, Volume XI (2008-2012; 22 countries), and the World Health Organization Mortality Database (2006-2016; 38 countries).

RESULTS

BTC incidence varied by country, with the highest in Chile (14.35) and the lowest in Vietnam (1.25). Mortality rates for BTC were highest for the Republic of Korea (11.64) and lowest for the Republic of Moldova (1.65). BTC mortality rates increased over time in 24 of 34 countries. Patients aged ≥75 years had 5-10 times higher mortality rates than the overall BTC rate in all countries. In most countries, incidence rates were highest for GBC, and mortality rates highest for ICC, while both were lowest for AVC. Females had and died from GBC more frequently than males. For ICC, extrahepatic cholangiocarcinoma, and AVC, males trended toward higher incidence and mortality rates.

CONCLUSION

The increasing incidence and mortality trends reported here indicate a need for improved prevention and treatment for all BTC subtypes.

摘要

背景与目的

胆道癌(BTC)由一组肝内和肝周肿瘤组成,这些肿瘤位置相近但解剖结构不同,包括胆囊癌(GBC)、胆管癌(肝外和肝内胆管癌[ICC])以及 Vater 壶腹癌(AVC)。大多数流行病学研究聚焦于一种或多种解剖学亚型,或者未将 BTC 与肝细胞癌或其他原发性肝癌区分开来。在此,我们提供了 BTC 总体及按解剖学亚型划分的全球发病率和死亡率的描述性最新数据。

方法

年龄标准化发病率(每 10 万人年)源自国际癌症研究机构的《五大洲癌症发病率》第十一卷(2008 - 2012 年;22 个国家)以及世界卫生组织死亡率数据库(2006 - 2016 年;38 个国家)。

结果

BTC 的发病率因国家而异,智利最高(14.35),越南最低(1.25)。BTC 的死亡率韩国最高(11.64),摩尔多瓦共和国最低(1.65)。在 34 个国家中的 24 个国家,BTC 的死亡率随时间增加。在所有国家,年龄≥75 岁的患者死亡率比 BTC 总体死亡率高 5 - 10 倍。在大多数国家,GBC 的发病率最高,ICC 的死亡率最高,而 AVC 的发病率和死亡率均最低。女性患 GBC 并死于该病的频率高于男性。对于 ICC、肝外胆管癌和 AVC,男性的发病率和死亡率有上升趋势。

结论

此处报告的发病率和死亡率上升趋势表明,需要改进所有 BTC 亚型的预防和治疗措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11307584/ae38e0e9dc9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11307584/a7e5f9c27b53/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11307584/ae38e0e9dc9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11307584/a7e5f9c27b53/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11307584/ae38e0e9dc9d/gr2.jpg

相似文献

1
Worldwide Incidence and Mortality of Biliary Tract Cancer.全球胆管癌的发病率和死亡率
Gastro Hep Adv. 2022 Apr 15;1(4):618-626. doi: 10.1016/j.gastha.2022.04.007. eCollection 2022.
2
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.美国胆道癌的流行病学模式:2001-2015 年。
BMC Cancer. 2022 Nov 16;22(1):1178. doi: 10.1186/s12885-022-10286-z.
3
The epidemiological trends of biliary tract cancers in the United States of America.美国胆道癌的流行病学趋势。
BMC Gastroenterol. 2022 Dec 29;22(1):546. doi: 10.1186/s12876-022-02637-8.
4
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.美国胆道癌发病率和趋势按人口统计学分组,1999-2013 年。
Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.
5
Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project.女性生殖因素与胆道癌的关系:来自胆道癌汇集项目的研究。
J Hepatol. 2020 Oct;73(4):863-872. doi: 10.1016/j.jhep.2020.04.046. Epub 2020 May 11.
6
Descriptive epidemiology of biliary tract cancer incidence and geographic variation in Japan.日本胆道癌发病率及地理差异的描述性流行病学
Eur J Cancer Prev. 2023 Jan 1;32(1):2-9. doi: 10.1097/CEJ.0000000000000758. Epub 2022 Apr 26.
7
Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.2010-2016 年美国晚期胆道癌远处转移模式及当前化疗疗效的研究。
Cancer Med. 2020 Feb;9(4):1335-1348. doi: 10.1002/cam4.2794. Epub 2019 Dec 26.
8
Incidence and mortality trends for biliary tract cancers in Austria.奥地利胆道癌的发病率和死亡率趋势。
Liver Int. 2014 Aug;34(7):1102-8. doi: 10.1111/liv.12325. Epub 2013 Oct 2.
9
Genetic alterations in Japanese extrahepatic biliary tract cancer.日本肝外胆管癌的基因改变。
Oncol Lett. 2017 Jul;14(1):877-884. doi: 10.3892/ol.2017.6224. Epub 2017 May 22.
10
Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.美洲的胆囊和肝外胆管癌:发病和死亡模式及趋势。
Int J Cancer. 2020 Aug 15;147(4):978-989. doi: 10.1002/ijc.32863. Epub 2020 Jan 21.

引用本文的文献

1
Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity.高迁移率族蛋白盒1在胆管癌中的高表达及其与细胞生长、体外迁移和侵袭以及化疗药物敏感性的关系。
Sci Prog. 2025 Jul-Sep;108(3):368504251362343. doi: 10.1177/00368504251362343. Epub 2025 Jul 21.
2
SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025).SEOM-GEMCAD-TTD 2025年胆道癌临床指南
Clin Transl Oncol. 2025 May 30. doi: 10.1007/s12094-025-03916-y.
3
Precision oncology in biliary tract cancer: the emerging role of liquid biopsy.

本文引用的文献

1
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.肝胆肿瘤,2.2021 年版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 May 1;19(5):541-565. doi: 10.6004/jnccn.2021.0022.
2
The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017.1990年至2017年195个国家和地区胆囊癌和胆道癌的全球、区域和国家负担及其归因风险因素:全球疾病负担研究2017的系统分析
Cancer. 2021 Jul 1;127(13):2238-2250. doi: 10.1002/cncr.33476. Epub 2021 Mar 22.
3
胆道癌的精准肿瘤学:液体活检的新兴作用
ESMO Open. 2025 Apr 30;10(5):105079. doi: 10.1016/j.esmoop.2025.105079.
4
Epidemiology and genomic features of biliary tract cancer and its unique features in Korea.韩国胆道癌的流行病学、基因组特征及其独特特性
J Liver Cancer. 2025 Mar;25(1):41-51. doi: 10.17998/jlc.2025.02.27. Epub 2025 Mar 4.
5
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer.晚期胆管癌的免疫格局及其免疫治疗潜力
Curr Oncol. 2024 Dec 31;32(1):24. doi: 10.3390/curroncol32010024.
6
An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990-2021.1990 - 2021年204个国家和地区因高体重指数导致的胆囊癌和胆管癌全球疾病负担分析
Front Nutr. 2024 Dec 16;11:1521770. doi: 10.3389/fnut.2024.1521770. eCollection 2024.
7
Digestive cancers: mechanisms, therapeutics and management.消化系统癌症:机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
8
Metagenomic characterization of oral microbiome signatures to predict upper gastrointestinal and pancreaticobiliary cancers: a case-control study.通过口腔微生物组特征的宏基因组学表征预测上消化道和胰腺胆管癌:一项病例对照研究
J Transl Med. 2025 Jan 6;23(1):20. doi: 10.1186/s12967-024-05989-9.
9
Epidemiology of biliary tract cancer in China: A narrative review.中国胆管癌的流行病学:一篇叙述性综述。
Chin J Cancer Res. 2024 Oct 30;36(5):474-488. doi: 10.21147/j.issn.1000-9604.2024.05.02.
10
Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.高身体质量指数对中国胆囊和胆道癌负担的影响:1990 年至 2021 年趋势的综合分析。
World J Surg Oncol. 2024 Nov 12;22(1):296. doi: 10.1186/s12957-024-03582-4.
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
当前和新型的系统治疗在胆管癌中的治疗机会。
Br J Cancer. 2020 Sep;123(7):1047-1059. doi: 10.1038/s41416-020-0987-3. Epub 2020 Jul 22.
4
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.ivosidenib 治疗 IDH1 突变、化疗耐药性胆管癌(ClarIDHy):一项多中心、随机、双盲、安慰剂对照、3 期研究。
Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
5
Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study.慢性乙型或丙型肝炎病毒感染者的肝外癌症发病情况:一项全国性队列研究。
J Viral Hepat. 2020 Sep;27(9):896-903. doi: 10.1111/jvh.13304. Epub 2020 May 18.
6
The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.年龄和合并症对接受姑息性化疗的晚期或复发性胆道癌的影响。
J Gastroenterol Hepatol. 2020 Oct;35(10):1828-1835. doi: 10.1111/jgh.15066. Epub 2020 Apr 23.
7
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.培米替尼治疗既往治疗过的局部晚期或转移性胆管癌:一项多中心、开放标签、2 期研究。
Lancet Oncol. 2020 May;21(5):671-684. doi: 10.1016/S1470-2045(20)30109-1. Epub 2020 Mar 20.
8
Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.美洲的胆囊和肝外胆管癌:发病和死亡模式及趋势。
Int J Cancer. 2020 Aug 15;147(4):978-989. doi: 10.1002/ijc.32863. Epub 2020 Jan 21.
9
Epidemiology of gallbladder cancer.胆囊癌流行病学
Clin Exp Hepatol. 2019 May;5(2):93-102. doi: 10.5114/ceh.2019.85166. Epub 2019 May 23.
10
Epidemiology of gallbladder cancer in India.印度胆囊癌的流行病学
Chin Clin Oncol. 2019 Aug;8(4):33. doi: 10.21037/cco.2019.08.03.